MADISON OBERLANDER: Open Payments
NPI 1467056507 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 23 payments from 6 companies in 2025. Trend: 2023 $1,166 · 2024 $472 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $400 |
| GlaxoSmithKline, LLC. | 6 | $99 |
| Optinose US, Inc. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
